Prescription Drugs

• KFF Health News: Lack of Affordability Tops Older Americans’ List of Health Care Worries

  July 11, 2024: What weighs most heavily on older adults’ minds when it comes to health care? The cost of services and therapies, and their ability to pay. “It’s on our minds a whole lot because of our age and because everything keeps getting more expens...Read more >

• KFF Health News: Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice

  September 21, 2023: Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment. So when nine Humira knockoffs, known as biosimilars, ...Read more >

• Hearing Exposes Greed of Drug Corporation AbbVie

  May 24, 2021: According to a study released on May 18 by the U.S. House Oversight and Reform Committee, the pharmaceutical corporation AbbVie has raised prices 470% in the United States for its widely used drugs Humira and Imbruvica over the past two decades. The ...Read more >

• KHN: As Drug Prices Keep Rising, State Lawmakers Propose Tough New Bills to Curb Them

  February 16, 2021: Fed up with a lack of federal action to lower prescription drug costs, state legislators around the country are pushing bills to penalize drugmakers for unjustified price hikes and to cap payment at much-lower Canadian levels. These bills, sponsor...Read more >

• KHN: Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets

  January 07, 2021: Sharon Clark is able to get her life-sustaining cancer drug, Pomalyst — priced at more than $18,000 for a 28-day supply — only because of the generosity of patient assistance foundations. Clark, 57, a former insurance agent who lives in Bixby,...Read more >